CME Group Inc. stock holds near 52-week high after insider share sale
Published on 09/15/2026 at 18:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CME Group Inc. stock (ISIN US12572Q1058) was quoted around USD 280.46 on Nasdaq on September 14, 2026, keeping the derivatives exchange operator close to its recent 52-week high as investors digested fresh insider activity and the latest earnings figures.
Insider sale at elevated share price
According to Investing.com on September 15, 2026, CME Group director Elizabeth A. Cook sold 500 shares of the company’s Class A common stock on September 14, 2026 at a price of USD 280.11 per share, for a total transaction value of USD 140,055.
The same report states that the transaction occurred near the prevailing market price of CME Group stock, quoted at USD 280.46 as of the close, implying that Cook’s sale was executed with less than USD 0.40 difference between the sale price and the closing price, a very narrow spread at this level.Investing.com
Share price, valuation and recent earnings
Per the insider-trading coverage from Investing.com on September 15, 2026, CME Group’s share price at USD 280.46 corresponds to a market capitalization of roughly USD 100.85 billion, underscoring the company’s status as one of the largest exchange operators globally.
As MarketBeat reported on September 14, 2026, CME Group last released quarterly earnings on July 22, 2026, posting earnings per share of USD 2.99 for the period, which exceeded the analysts’ consensus estimate of USD 2.91 by USD 0.08.
In the same update, MarketBeat highlighted that CME Group generated quarterly revenue of USD 1.71 billion for that reporting period, compared with analysts’ expectations of USD 1.68 billion, a positive variance of USD 0.03 billion or about 1.8 percent against the consensus.
The same earnings coverage notes that quarterly revenue increased 0.8 percent compared to the same quarter a year earlier, helping the company maintain a net margin of 63.30 percent and a return on equity of 15.60 percent for the period, figures that underline CME Group’s highly profitable business model.MarketBeat
Analyst view and dividend context
According to the same analyst overview from MarketBeat, CME Group currently carries a consensus rating of Hold with an average analyst price target of USD 289.75, placing that target roughly USD 9.29 above the recent closing price of USD 280.46 and implying about 3.3 percent upside from that level if the target were reached.
The same source indicates that research analysts expect CME Group Inc. to post earnings per share of 12.27 for the current year, which, if achieved, would be consistent with the strong profitability metrics in the latest reported quarter.MarketBeat
Historical dividend data in the same MarketBeat report show that CME Group previously declared a quarterly dividend of USD 1.30 per share, corresponding to an annualized dividend of USD 5.20 and a yield of 1.9 percent at the time of that past reference price, with a payout ratio cited at 44.11 percent; these values serve as a historical benchmark for the company’s capital-return policy.MarketBeat
Stock level and investor takeaway
With CME Group Inc. stock closing at USD 280.46 on Nasdaq on September 14, 2026, and director Elizabeth Cook’s insider sale executed at USD 280.11 on the same date, the share price is trading close to the average analyst target of USD 289.75 while reflecting the company’s robust margins and steady revenue growth in the latest reported quarter.
CME Group Inc. stock facts
- Company: CME Group Inc.
- ISIN: US12572Q1058
- Ticker: CME
- Trading venue: Nasdaq
- Price (as of September 14, 2026): 280.46 USD
- Market capitalization: 100.85 billion USD (as of September 15, 2026)
- Sector / Industry: Financials / Exchanges and data
- Index membership: S&P 500
